LONG PULSE LASER TREATMENT OF PSORIASIS

Information

  • Research Project
  • 2083272
  • ApplicationId
    2083272
  • Core Project Number
    R43AR043559
  • Full Project Number
    1R43AR043559-01
  • Serial Number
    43559
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/25/1995 - 29 years ago
  • Project End Date
    3/24/1996 - 28 years ago
  • Program Officer Name
  • Budget Start Date
    9/25/1995 - 29 years ago
  • Budget End Date
    3/24/1996 - 28 years ago
  • Fiscal Year
    1995
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/21/1995 - 29 years ago
Organizations

LONG PULSE LASER TREATMENT OF PSORIASIS

DESCRIPTION: (Adapted from applicant's abstract) The investigators will study the efficacy of long pulsed laser treatment for psoriasis. Psoriasis is a common disease which is often chronic in nature. Current treatment modalities do not result in a cure of this chronic disease. The investigators wish to develop a safe and efficacious dye laser for psoriasis. The laser radiation will be optimized for its selective absorption by erythrocytes in the capillaries of the dermal papillae. Subsequent thermal necrosis of the microvasculature and surrounding skin structures is expected to reduce the interaction of the papillary dermis with the epidermis and temporarily halt the disease process. Preliminary results show that 0.4 msec pulses from a dye laser can reduce the thickness of a psoriatic plaque. This phase I effort will construct a 1.5 msec dye laser to expand the zone of damage and improve responsiveness of the psoriasis. PROPOSED COMMERCIAL APPLICATION: The commercial potential of the laser is quite good if it is successful at treating psoriasis and maintaining a remission for a period of months. Currently, topical corticosteroid therapy is quite expensive as pointed out by the authors. In addition, retinoids, antimetabolites and light therapy are all expendsive with significantly more toxicity than would be experienced with most laser therapy.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R43
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    CANDELA CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    WAYLAND
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01778
  • Organization District
    UNITED STATES